Officials at Becton Dickinson, a New Jersey-based medical technology company, have announced the closure of its plant at 9400 Science Center Drive, New Hope. The plant manufactures Lutonix drug-coated balloons, a device used to treat narrowed or blocked blood vessels.
The plant employs 85 workers, 53 who face layoffs. The remaining 32 employees will work remotely or be transferred to the company’s Tempe, Arizona, location.
The company said the closure is part of an ongoing effort to consolidate its peripheral interventions business. The U.S. Food and Drug Administration announced in August that use of the Lutonix balloon is not advisable in some parts of the body. Similar research published in the Journal of the American Heart Association in December 2018 found that use of the coated balloon and stents could be linked to a higher risk of death in some patients.
The closure will go into effect March 31.